Close Menu

NEW YORK – Bio-Rad Laboratories reported Thursday after the close of the market that its second quarter revenues fell 6 percent year over year, primarily due to COVID-19 pandemic-related slowdowns.

For the three months ended June 30, 2020, Bio-Rad reported revenues of $536.9 million compared to $572.6 million a year ago, besting analysts' average estimate of $517.1 million.

On a currency-neutral basis, Q2 revenues decreased about 4 percent, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.